Kaur, P., Chow, V., Zhang, N., Moxness, M., Kaliyaperumal, A., & Markus, R. (2017). A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab. Ann Rheum Dis.
Chicago Style CitationKaur, Primal, Vincent Chow, Nan Zhang, Michael Moxness, Arunan Kaliyaperumal, i Richard Markus. "A Randomised, Single-blind, Single-dose, Three-arm, Parallel-group Study in Healthy Subjects to Demonstrate Pharmacokinetic Equivalence of ABP 501 and Adalimumab." Ann Rheum Dis 2017.
Cita MLAKaur, Primal, et al. "A Randomised, Single-blind, Single-dose, Three-arm, Parallel-group Study in Healthy Subjects to Demonstrate Pharmacokinetic Equivalence of ABP 501 and Adalimumab." Ann Rheum Dis 2017.